These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2454155)

  • 1. Interferon in multiple sclerosis.
    Färkkilä M; Iivanainen M
    Clin Neuropharmacol; 1988 Apr; 11(2):120-9. PubMed ID: 2454155
    [No Abstract]   [Full Text] [Related]  

  • 2. Infectious Diseases Society of America. Trials of interferon therapy for multiple sclerosis.
    Abb J; Deinhardt F; Zander H; Tenser RB; Rapp F; Goust JM; Fudenberg HH; Vilcek J; Ho M; Merigan TC; Oldstone MB; Jackson GG
    J Infect Dis; 1982 Jul; 146(1):109-15. PubMed ID: 6177805
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interferon-producing and cytotoxic activity of natural killer cells in multiple sclerosis patients].
    Sorokin AM; Koval'chuk LV; Tunkel' OI; Cheknev SB
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(2):211-5. PubMed ID: 2437743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple sclerosis; current developments in the pathogenesis and treatment].
    van Lambalgen R; Sanders EA
    Ned Tijdschr Geneeskd; 1984 Sep; 128(35):1669-73. PubMed ID: 6207446
    [No Abstract]   [Full Text] [Related]  

  • 5. [Immunological abnormalities in multiple sclerosis].
    Tabira T
    No To Shinkei; 1983 Jun; 35(6):535-41. PubMed ID: 6194805
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of experimental recombinant interferons on multiple sclerosis.
    Johnson KP; Panitch HS
    Trans Am Clin Climatol Assoc; 1989; 100():171-6. PubMed ID: 2479162
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of interferon production and natural killing by lymphocytes from multiple sclerosis patients.
    Neighbour PA
    Ann N Y Acad Sci; 1984; 436():181-91. PubMed ID: 6085226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis.
    Vandenbark AA; Huan J; Agotsch M; La Tocha D; Goelz S; Offner H; Lanker S; Bourdette D
    J Neuroimmunol; 2009 Oct; 215(1-2):125-8. PubMed ID: 19758707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Etiology and treatment of multiple sclerosis].
    Itoyama Y
    Nihon Naika Gakkai Zasshi; 2001 Sep; 90(9):1827-32. PubMed ID: 11681067
    [No Abstract]   [Full Text] [Related]  

  • 10. Interferon therapy for multiple sclerosis.
    Johnson KP; Panitch HS
    Md Med J; 1992 Jul; 41(7):601-3. PubMed ID: 1379317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killing activity and interferon production in multiple sclerosis.
    Zander H; Abb J; Kaudewitz P; Riethmüller G
    Lancet; 1982 Jan; 1(8266):280. PubMed ID: 6173558
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple sclerosis.
    Ellison GW; Visscher BR; Graves MC; Fahey JL
    Ann Intern Med; 1984 Oct; 101(4):514-26. PubMed ID: 6206758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon in multiple sclerosis.
    Hendel DL; Hart LL
    DICP; 1990 Feb; 24(2):158-60. PubMed ID: 1689920
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interferon therapy in multiple sclerosis. Mechanism of action, side effects, results].
    Huber M
    Nervenarzt; 1988 Sep; 59(9):514-20. PubMed ID: 2460777
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunoregulatory properties of type-I interferons: relevance to multiple sclerosis and the hypereosinophilic syndrome.
    Bartholomé EJ; Roufosse FE
    Acta Clin Belg; 1997; 52(6):350-9. PubMed ID: 9489130
    [No Abstract]   [Full Text] [Related]  

  • 16. Variability of natural killer activity during immunotherapy.
    Cheknev SB
    Bull Exp Biol Med; 2004 Feb; 137(2):171-4. PubMed ID: 15273767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic interferon therapy for multiple sclerosis. Design of a trial.
    Johnson KP
    Arch Neurol; 1983 Oct; 40(11):681-2. PubMed ID: 6194777
    [No Abstract]   [Full Text] [Related]  

  • 18. Intrathecal interferon for multiple sclerosis.
    Berry CC
    Science; 1982 Jul; 217(4556):269-70. PubMed ID: 6178161
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interferons in multiple sclerosis].
    Milo R; Panitch H
    Harefuah; 1994 Apr; 126(8):451-8. PubMed ID: 7520880
    [No Abstract]   [Full Text] [Related]  

  • 20. New hope for multiple sclerosis victims via an improved, inexpensive, orthomolecular, interferon clinical protocol.
    Stone I
    Australas Nurses J; 1982 Apr; 11(3):13-5. PubMed ID: 6180724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.